First published in 1998. The purpose of this book is to provide prescribing psychologists and psychology students with an accurate and authoritative reference for psychotropic drugs that are commonly available for clinical prescription in North America. The reference is particularly directed for use by psychologists and psychology students who already have, or are currently developing, their professional expertise and responsibilities in the prescription and management of psychotropic pharmacotherapy as an adjunct to their psychotherapy. The Reference lists detailed drug monographs for over 100 different prescription psychotropic drugs available in North America. Thus, this reference is the most comprehensive psychotropic drug reference for clinical psychologists currently available. Each psychotropic monograph is clearly and concisely written to only reflect essential and important data that are commonly required by prescribing psychologists. Whenever available and appropriate, each monograph includes phonetic pronunciation, up to five common trade or brand names, pharmacologic or therapeutic classification and subclassification, United States Drug Enforcement Agency (USDEA) schedule designation for abuse potential, recommended dosages for adults, children and the elderly, helpful and important notes regarding methods of administration, relative contraindications, clinically significant drug interactions and more. It is hoped that by using the information presented in is book prescribing psychologists and psychology students will be better able to provide their patients with the maximum benefits of adjunctive pharmacotherapy with a minimum of adverse and toxic effects.

This volume traces the modern critical and performance history of this play, one of Shakespeare's most-loved and most-performed comedies. The essay focus on such modern concerns as feminism, deconstruction, textual theory, and queer theory.

First published in 1999. This comprehensive neuropsychotropic drug reference is designed with prescribing psychologists and psychology students in mind. An accurate and authoritative reference, the Psychologists' Neuropsychotropic Drug Reference (PNDR) details drug monographs for over 80 different prescription neuropsychotropic drugs available for clinical prescription in North America. Each neuropsychotropic monograph is clearly and concisely written to reflect essential and important data that are commonly required by prescribing psychologists and psychology students. Thus, whenever possible and appropriate, each monograph includes: a phonetic pronunciation guide; up to five common trade or brand names; pharmacologic or therapeutic classification and subclassification; USDEA schedule designation for abuse potential; recommended dosages; and many other critical details. The form, style, and content of each monograph has been reviewed by members of an Editorial Advisory Committee of distinguished psychologists. With this quality assurance, this text is certain to become an asset to prescribing psychologists and psychology students as they strive to provide the maximum benefit of neuropsychotropic pharmacotherapy.

Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis.

Print+CourseSmart

Praise for Handbook of Clinical Psychopharmacology for Psychologists "Handbook of Clinical Psychopharmacology for Psychologists is a remarkably thorough introductory textbook for integrating psychotropic drug prescribing into psychological practices. It covers basic concepts in physiology, neurology, and pharmacology in easily understood language. Not only is this book a requirement for any psychologist seeking to gain prescriptive authority, but it is also helpful for any mental health clinician who collaborates with prescribers of any discipline. I recommend it highly." Daniel Carlat, MD, Editor in Chief of The Carlat Psychiatry Report "An important resource for any psychologist who is preparing to become a prescribing psychologist or for any psychologist who wants to be informed about the practice of medical psychology." Joseph E. Comaty, PhD, MP, coauthor of A Primer of Drug Action "Handbook of Clinical Psychopharmacology for Psychologists is an excellent treatise written by psychologists for psychologists." From the Foreword by Patrick H. DeLeon, PhD, and Jack G. Wiggins, PhD, former presidents of the American Psychological Association An essential and practical guide to integrating psychopharmacology into clinical practice Edited by medical psychologists with contributions by notable experts in their respective specialties, Handbook of Clinical Psychopharmacology for Psychologists covers key topics including: Ethics, standards of care, laws, and regulations relevant to clinical psychopharmacology Disorders of the nervous system, with particular relevance to psychopharmacology Use of comprehensive diagnostic strategies to establish differential diagnoses among possible medical and psychological symptoms Integration of pharmacotherapy with psychotherapy This essential book also provides an introduction to the qualifying exam for psychologists seeking specialty training in psychopharmacology, the Psychopharmacology Exam for Psychologists (PEP). The PEP-like practice test is available on the companion CD-ROM.

With its strong practical orientation, this book is a must-read for psychologists who have or want to obtain prescriptive authority, as well as those who wish to assume more collaborative roles within primary care and other settings."--pub. desc.

Updated with bonus material, including a new foreword and afterword with new research, this New York Times bestseller is essential reading for a time when mental health is constantly in the news. In this astonishing and startling book, award-winning science and history writer Robert Whitaker investigates a medical mystery: Why has the number of disabled mentally ill in the United States tripled over the past two decades? Interwoven with Whitaker’s groundbreaking analysis of the merits of psychiatric medications are the personal stories of children and adults swept up in this epidemic. As Anatomy of an Epidemic reveals, other societies have begun to alter their use of psychiatric medications and are now reporting much improved outcomes . . . so why can’t such change happen here in the United States? Why have the results from these long-term studies—all of which point to the same startling conclusion—been kept from the public? Our nation has been hit by an epidemic of disabling mental illness, and yet, as Anatomy of an Epidemic reveals, the medical blueprints for curbing that epidemic have already been drawn up. Praise for Anatomy of an Epidemic “The timing of Robert Whitaker’s Anatomy of an Epidemic, a comprehensive and highly readable history of psychiatry in the United States, couldn’t be better.”—Salon “Anatomy of an Epidemic offers some answers, charting controversial ground with mystery-novel pacing.”—TIME “Lucid, pointed and important, Anatomy of an Epidemic should be required reading for anyone considering extended use of psychiatric medicine. Whitaker is at the height of his powers.” —Greg Critser, author of Generation Rx

TABLE OF CONTENTS: 1 General Principles. 2 Depression. 3 Bipolar Illness. 4 Anxiety Disorders. 5 Psychotic Disorders. 6 Miscellaneous Disorders. 7 non-Response and "Breakthrough Symptoms" Algorithms. 8 Case Examples. App. A- History and personal Data Questionnaire. App. B- Special Cautions When Taking MAO Inhibitors.

Now in its fourth edition, this book continues to present valuable information in a clear, accessible format.